Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +0.64% sank 0.44% to $167.10 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +1.03% falling 1.84% to 4,577.11 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.79% falling 1.51% to 35,368.47. This was the stock's sixth consecutive day of losses. Johnson & Johnson closed $12.82 below its 52-week high ($179.92), which the company achieved on August 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -2.04% fell 0.52% to $395.45, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +1.56% rose 0.20% to $81.54, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +2.80% fell 1.53% to $54.11. Trading volume (7.3 M) remained 135,653 below its 50-day average volume of 7.5 M.